Roche, Xofluza
Roche reports positive data from Phase III influenza treatment trial
According to the findings, the antiviral treatment demonstrated to significantly reduce the transmission of influenza viruses.
Roche’s Xofluza reduces flu transmission in Phase 3 study
According to the company, the results are the first time an antiviral drug has reduced transmission of a respiratory virus in a global Phase 3 trial.
Baloxavir Marboxil Reduces Onward Transmission of Influenza
Treatment with baloxavir marboxil significantly reduced the risk of onward transmission of influenza within households.
Positive Phase III Results Show Xofluza Significantly Reduces the Transmission of Influenza Viruses
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results of the Phase III CENTERSTONE study of Xofluza® (baloxavir marboxil), an antiviral, showing a reduction in the transmission of influenza viruses.
Roche's Antiviral Drug Reduces Transmission Of Influenza Viruses, Late-Stage Study Shows
Roche's phase 3 CENTERSTONE study shows Xofluza (baloxavir marboxil) significantly reduces influenza transmission in households, marking a global first for an antiviral.
Roche touts positive Phase III results with Xofluza
Roche today released positive top-line results of the Phase III CENTERSTONE study of Xofluza (baloxavir marboxil), an antiviral, showing a reduction in the transmission of influenza viruses.
Roche's Xofluza Reduces Influenza Transmission In Phase III Study
The company noted that CENTERSTONE is the first global phase III study to show a transmission reduction benefit with an antiviral used in the treatment of a respiratory viral illness. This new data may add to the benefits of Xofluza, which is currently approved for treating symptoms and preventing infection following virus exposure.
Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses
Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses: Basel Friday, September 20, 2024, 09:00 Hrs [IST] Roche announc
Undark2d
Could an Old Drug Protect Against a New Pandemic?
Health authorities have said that stockpiled Tamiflu should work well against H5N1. Some experts question that bet.
Can our stockpiles of Tamiflu protect against a bird flu pandemic?
In terms of how quickly they alleviate symptoms, oseltamivir and baloxavir are on par, said Yen. But baloxavir is better at ...
Health Affairs4d
How Policy Makers Can Act Now To Prevent An Avian Influenza Pandemic
It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...
Roche unit hits main goal in late-stage trial for flu therapy
Roche (RHHBF) unit Genentech said Xofluza antiviral reached the main goal in a global Phase 3 trial, reducting the ...
MarketWatch6d
Roche Says Xofluza Achieves Positive Results in Phase 3 Trial
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...